SAR and species/stereo-selective metabolism of the sorbitol dehydrogenase inhibitor, CP-470,711

SAR studies on the stereoisomers of CP-470,711 suggested that in vivo epimerization was taking place in rats. Further metabolism studies revealed that no epimerization was occurring in dogs, and that no epimerization was expected in humans. A mechanism for the in vivo epimerization is proposed invol...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters Vol. 12; no. 11; pp. 1477 - 1480
Main Authors: Chu-Moyer, Margaret Y., Ballinger, William E., Beebe, David A., Coutcher, James B., Day, Wesley W., Li, Jiancheng, Oates, Peter J., Weekly, R.Matthew
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 03-06-2002
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SAR studies on the stereoisomers of CP-470,711 suggested that in vivo epimerization was taking place in rats. Further metabolism studies revealed that no epimerization was occurring in dogs, and that no epimerization was expected in humans. A mechanism for the in vivo epimerization is proposed involving an oxidation–reduction pathway of the secondary benzylic alcohol, in contrast to an acid/base-promoted epimerization of the same center during chemical synthesis. In vivo pharmacological and drug metabolism studies revealed that CP-470,711 ( 1) undergoes epimerization in rat, but not dog. In vitro studies suggest that 1 will not epimerize in humans.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/S0960-894X(02)00208-1